NCT02934724View on ClinicalTrials.gov

Impact of HPV Vaccine On The Prevalence Of HPV In Norway

CompletedOBSERVATIONAL
Enrollment

315

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Cervical Intraepithelial NeoplasiaCervical CancerOropharyngeal Cancer
Interventions
PROCEDURE

Self sample from vagina

Self sample using The Rover's Evalyn Brush

PROCEDURE

Self sample from the oral cavity

Self sample using COPAN FloqSwab

OTHER

Questionnaire

Questionnaire about vaccination status and sexual behaviour

Trial Locations (1)

0379

Oslo University Hospital, Cancer Registry of Norway, Oslo

All Listed Sponsors
collaborator

University Hospital, Akershus

OTHER

lead

Oslo University Hospital

OTHER

NCT02934724 - Impact of HPV Vaccine On The Prevalence Of HPV In Norway | Biotech Hunter | Biotech Hunter